Reduction of the risk of transfusion-transmitted human immunodeficiency virus (HIV) infection by using an HIV antigen/antibody combination assay in blood donation screening in Cameroon.
about
Estimate of the residual risk of transfusion-transmitted human immunodeficiency virus infection in sub-Saharan Africa: a multinational collaborative study.Reducing risks of Transfusion-transmitted infections in a resource-limited hospital-based blood bank: the case of the Yaoundé University Teaching Hospital, Cameroon.The risk of transfusion-transmitted viral infections at the Gabonese National Blood Transfusion Centre.Estimation of the prevalence and rate of acute transfusion reactions occurring in Windhoek, Namibia.Investments in blood safety improve the availability of blood to underserved areas in a sub-Saharan African country.Transfusion safety in francophone African countries: an analysis of strategies for the medical selection of blood donors.Screening for hepatitis C virus infection in a high prevalence country by an antigen/antibody combination assay versus a rapid test.[The francophone Africa blood transfusion research network: a five-year report].Risk factors for human immunodeficiency virus among blood donors in Cameroon: evidence for the design of an Africa-specific donor history questionnaire.The contribution of unsafe blood transfusion to human immunodeficiency virus incidence in sub-Saharan Africa: reexamination of the 5% to 10% convention.High prevalence of HIV p24 antigen among HIV antibody negative prospective blood donors in Ile-Ife, Nigeria.Gag P2/NC and pol genetic diversity, polymorphism, and drug resistance mutations in HIV-1 CRF02_AG- and non-CRF02_AG-infected patients in Yaoundé, Cameroon.Multinational assessment of blood-borne virus testing and transfusion safety on the African continent.Dried Blood Spots for Use in HIV-Related Epidemiological Studies in Resource-Limited Settings
P2860
Q30394281-33F44EF4-EF80-405D-A2B9-3262F9259B44Q33459249-8FB6AC18-65A4-422E-9C4E-6187276A08D3Q33953427-0F245659-228F-480B-A52D-AB4C9F24BEACQ33953448-0173132C-95DF-45E5-9223-6224A0877C98Q36171147-4E9E0938-BB05-4982-B63B-894432FCF512Q36890459-7751CE7F-53C3-4638-BDAD-FE641A2829C5Q37296858-98A4ECBD-8746-4F4D-9F0B-21D323F81EE1Q37309442-AE0FE626-DF0F-447E-8CA5-35DE47980178Q38784141-833189CB-A278-4657-857A-6040B4EB00B4Q38963030-95ED161F-4869-4643-A64B-135C0244DF5AQ39860142-677D285A-24CC-466D-81F0-76DE7B69EC46Q42620819-4A95E97D-05FC-4883-9A02-A916B067DFDBQ42982287-70DC5931-8CF9-47C7-8327-4DCAF7DBDB90Q58488463-85A1B8CE-9678-4589-95A9-6E7552A6682E
P2860
Reduction of the risk of transfusion-transmitted human immunodeficiency virus (HIV) infection by using an HIV antigen/antibody combination assay in blood donation screening in Cameroon.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
2011年學術文章
@zh-hant
name
Reduction of the risk of trans ...... onation screening in Cameroon.
@en
Reduction of the risk of transfusion-transmitted human immunodeficiency virus
@nl
type
label
Reduction of the risk of trans ...... onation screening in Cameroon.
@en
Reduction of the risk of transfusion-transmitted human immunodeficiency virus
@nl
prefLabel
Reduction of the risk of trans ...... onation screening in Cameroon.
@en
Reduction of the risk of transfusion-transmitted human immunodeficiency virus
@nl
P2093
P2860
P921
P1433
P1476
Reduction of the risk of trans ...... onation screening in Cameroon.
@en
P2093
Claude Tayou Tagny
Dora Mbanya
Edward Murphy
Jean-Jacques Lefrère
Lionel Leballais
Syria Laperche
P2860
P304
P356
10.1111/J.1537-2995.2010.02782.X
P577
2011-01-01T00:00:00Z